Loading...
OTCM
BCHMF
Market cap7.81bUSD
Oct 08, Last price  
91.00USD
Name

Bachem Holding AG

Chart & performance

D1W1MN
OTCM:BCHMF chart
P/E
37.84
P/S
8.10
EPS
1.99
Vol. 1Y
—
Shs. 5Y
1.38%
Rev. 5Y
11.57%
Div Yld LY
—
Div Yld TTM
—
Revenues
695m
+14.84%
171,754,000198,318,000194,997,000181,848,000152,884,000145,808,000157,298,000170,685,000183,937,000208,604,000236,478,000261,612,000282,500,000313,715,000401,995,000503,234,000531,741,000577,316,000605,259,000695,070,000
Net income
149m
+23.74%
46,649,00063,927,00058,709,00046,057,00028,297,0009,409,00015,300,00023,604,00029,065,00031,838,00041,205,00041,770,00046,644,00054,164,00078,062,000114,682,000100,684,000111,859,000120,248,000148,793,000
CFO
271m
+85.46%
40,150,00078,070,00039,277,00042,847,00038,110,00024,609,00036,871,00049,230,00047,218,00061,434,00040,409,00036,479,00025,776,00063,648,000114,628,00097,163,00092,589,000249,864,000146,322,000271,362,000
Dividend
May 04, 20260.5743 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Bachem Holding AG is a global partner to pharmaceutical and biotechnology companies, supplying crucial products and services for every stage from early-stage research and clinical trials to full-scale commercialization. The company specializes in the creation, manufacturing, and regulatory assistance for peptide active pharmaceutical ingredients (APIs), particularly novel peptide and oligonucleotide chemical entities (NCEs). Beyond these, Bachem also offers established commercial NCEs and generic medications. Its comprehensive service offerings include project oversight, quality assurance, regulatory compliance guidance, advanced analytical testing, GMP-compliant production, specialized research-grade manufacturing, and integrated supply chain solutions. The company, established in 1971, operates from its headquarters in Bubendorf, Switzerland.

Key people

Kuno Sommer
Non-Executive Chairman of the Board · since 2012
Nicole Hoetzer
Non-Executive Vice Chairwoman of the Board · since 2011
Alain Schaffter
Chief Financial Officer, Member of the Corporate Executive Committee · since 2021
Thomas Meier
Chief Executive Officer, Chief Operating Officer, Member of the Corporate Executive Committee · since 2023
Guenther Loidl
Chief Technology Officer, Member of the Corporate Executive Committee · since 2015
Torsten Wohr
Chief Commercial Officer, Member of the Corporate Executive Committee · since 2023
Peter Grogg
Director · since 2025
Peter Grogg
Director · since 2025
Alex Faessler
Non-Executive Director · since 2021
Steffen Lang
Non-Executive Director · since 2020
Helma Wennemers
Non-Executive Director · since 2014
URL
https://www.bachem.com/
IPO date
Jun 29, 2001
Employees
1,926
Domiciled in
CH
Incorporated in
CH
Headquarters & legal address
Hauptstrasse 144
Bubendorf, BL 4416
CH
Other language
BACHEM HOLDING LTD
Other language
BACHEM HOLDING SA

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT